Sequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Clinical trial NCT04570943 · RECRUITING
Trial details
- NCT number
- NCT04570943
- Sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-16
- Primary completion
- 2028-01-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.